CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 189 filers reported holding CARA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18 | -100.0% | 10,451 | -99.0% | 0.00% | -100.0% |
| Q3 2021 | $16,042,000 | +7.3% | 1,038,314 | -0.9% | 0.00% | +100.0% |
| Q2 2021 | $14,948,000 | -70.1% | 1,047,488 | -54.4% | 0.00% | -80.0% |
| Q1 2021 | $49,918,000 | +35.8% | 2,299,299 | -5.3% | 0.01% | +25.0% |
| Q4 2020 | $36,754,000 | -9.1% | 2,429,235 | -23.6% | 0.00% | -20.0% |
| Q3 2020 | $40,440,000 | -36.0% | 3,177,992 | -14.0% | 0.01% | -37.5% |
| Q2 2020 | $63,198,000 | +23.8% | 3,695,802 | -4.4% | 0.01% | 0.0% |
| Q1 2020 | $51,062,000 | -32.0% | 3,865,390 | -17.1% | 0.01% | -20.0% |
| Q4 2019 | $75,082,000 | -11.4% | 4,660,614 | +0.5% | 0.01% | -16.7% |
| Q3 2019 | $84,761,000 | +40.8% | 4,636,827 | +65.6% | 0.01% | +50.0% |
| Q2 2019 | $60,207,000 | +21.1% | 2,800,339 | +10.5% | 0.01% | +14.3% |
| Q1 2019 | $49,709,000 | +58.3% | 2,533,590 | +4.9% | 0.01% | +40.0% |
| Q4 2018 | $31,401,000 | -45.8% | 2,415,491 | -0.1% | 0.01% | -37.5% |
| Q3 2018 | $57,893,000 | +540.3% | 2,417,235 | +412.0% | 0.01% | +700.0% |
| Q2 2018 | $9,041,000 | +52.4% | 472,136 | -1.5% | 0.00% | 0.0% |
| Q1 2018 | $5,933,000 | +1.1% | 479,275 | +0.0% | 0.00% | 0.0% |
| Q4 2017 | $5,866,000 | -6.1% | 479,213 | +5.0% | 0.00% | 0.0% |
| Q3 2017 | $6,246,000 | -14.1% | 456,253 | -3.4% | 0.00% | 0.0% |
| Q2 2017 | $7,273,000 | +35.8% | 472,553 | +62.2% | 0.00% | 0.0% |
| Q1 2017 | $5,356,000 | +110.1% | 291,258 | +14.8% | 0.00% | 0.0% |
| Q1 2015 | $2,549,000 | +0.8% | 253,635 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,529,000 | +18.7% | 253,635 | -0.1% | 0.00% | – |
| Q3 2014 | $2,130,000 | +1103.4% | 253,881 | +2342.8% | 0.00% | – |
| Q2 2014 | $177,000 | -93.9% | 10,393 | -93.3% | 0.00% | -100.0% |
| Q1 2014 | $2,896,000 | – | 155,622 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |